Director TitleAgeSince
Director/Board Member - 2010-09-30
Director/Board Member - 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
+1.97%+1.72%+13.54%+84.67% 47.15B
-2.16%+4.18%+66.45%+114.56% 37.94B
+0.45%+0.59%-3.05%+46.01% 12.35B
+1.21%-0.74%+11.37%+92.43% 11.52B
+2.59%-1.91%+32.47%+121.55% 8.93B
-0.08%-0.25%+22.32%+43.82% 7.14B
+1.29%+2.33%+54.48%-6.55% 7.02B
+1.36%+1.80%+24.81%+237.55% 6.51B
+6.55%+16.24%-23.92%+16.83% 5.98B
Average +17,991.32%+3.51%+22.05%+83.43% 16.06B
Weighted average by Cap. +0.98%+3.00%+28.38%+89.74%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock